Narendra Chirmule

9.7k citations

115 papers · 7.8k indexed · 2 hit papers · h-index 40

Impact in

Virology top 0.5%
- HIV Research and Treatment
Genetics top 0.2%
- Virus-based gene therapy research

Papers in

Virology 27
- HIV Research and Treatment 27
Immunology 64
- Biosimilars and Bioanalytical Methods 27
- Immune Cell Function and Interaction 23
- T-cell and B-cell Immunology 13

Co-authors: James M. Wilson Guangping Gao Savita Pahwa Steven E. Raper Mark L. Batshaw Nelson A. WivelYi ZhangAdam Bagg
Journals: Human Gene Therapy (11 papers)Journal of Virology (9 papers)The AAPS Journal (8 papers)Clinical and Vaccine Immunology (5 papers)The Journal of Immunology (5 papers)
Partner nations: United States India Japan

In The Last Decade

Narendra Chirmule

111 papers receiving 7.5k citations

Hit Papers

align trajectories log scale

Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer 2003 · 1.1k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2003 Molecular Genetics and Metabolism
1999 Gene Therapy

Peers

Countries citing papers authored by Narendra Chirmule

Since Specialization

Citations

This map shows the geographic impact of Narendra Chirmule's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Narendra Chirmule with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Narendra Chirmule more than expected).

Fields of papers citing papers by Narendra Chirmule

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Narendra Chirmule. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Narendra Chirmule. The network helps show where Narendra Chirmule may publish in the future.

Co-authors

The 25 scholars most cited alongside Narendra Chirmule, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Narendra Chirmule Line = papers co-authored together Narendra Chirmule links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Applications of Organoids in Advancing Drug Discovery and Development Journal of Pharmaceutical Sciences ·Indiwari Gopallawa, Charu Agrawal, James Crawford Kloes, Cécile Colomban, Vibha Jawa, Narendra Chirmule, Rubi kambo	2024	12
2	An Overview of Current Accomplishments and Gaps of COVID-19 Vaccine Platforms and Considerations for Next Generation Vaccines Journal of Pharmaceutical Sciences ·К. О. Vorotynseva, Amitabh Gaur, Ipshita Menon, Narendra Chirmule, Priyal Bagwe, Isabel Videira, Lal Dental, Nobuko TAKEUCHI, 施建英, Vibha Jawa	2023	1
3	Overcoming challenges to CAR-T cell therapies in India Cell and Gene Therapy Insights ·Uliana Bulyk, Ranjan Chakrabarti, Narendra Chirmule, Shashwati Basak, Fouad Atouf	2023	1
4	Teaching vaccine development in schools: Learnings from a survey and curriculum design for a course Frontiers in Education ·Haisong Qi, Yongfei Zhang, Narendra Chirmule, Jafet. asistente de la directora y regidor Ortiz, 正敏赤田, Steve Herron, R. Sanchez-Salas, 나희송	2023	1
5	Advanced strategies in glycosylation prediction and control during biopharmaceutical development: Avenues toward industry 4.0 Biotechnology Progress ·Yung San Kim, Joash Kirwah Kibet, Narendra Chirmule, Prajakta Dandekar, Ratnesh Jain	2022	4
6	Biopharmaceutical Industry Capability Building in India: Report from a Symposium Journal of Pharmaceutical Innovation ·Uliana Bulyk, Ranjan Chakrabarti, Narendra Chirmule, Anurag S. Rathore, Fouad Atouf	2021	7
7	Considerations for optimization and validation of an in vitro PBMC derived T cell assay for immunogenicity prediction of biotherapeutics Clinical Immunology ·M Vazquez Acosta, Lei Zhou, 美範鳥毛, Chanikan Yodya, Theresa J. Goletz, Steven J. Swanson, Narendra Chirmule, Vibha Jawa	2010	67
8	Identification and inhibition of drug target interference in immunogenicity assays Journal of Immunological Methods ·Zhandong Don Zhong, V S Ailawadi, Martha Hokom, Chad Ray, David M. Weinreich, Steven J. Swanson, Narendra Chirmule	2010	51
9	A Step-wise Approach for Transfer of Immunogenicity Assays during Clinical Drug Development The AAPS Journal ·Suyama Yasuhiro, Michael Moxness, Claudia Riediker, Lei Zhou, Michael Hale, Steven J. Swanson, Narendra Chirmule	2009	5
10	A novel chemistry for conjugating pneumococcal polysaccharides to Luminex microspheres Journal of Immunological Methods ·Michael Bentele, 成男小野, Narendra Chirmule, Mark T. Esser	2006	64
11	The optimization and validation of the glycoprotein ELISA assay for quantitative varicella-zoster virus (VZV) antibody detection Journal of Medical Virology ·Sandrine Maria Silva de Mendonça, Yue Wang, Tina Green, Joseph M. Antonello, Nadine Filko, Roy Carroll, Helen M. Campanha, Alex FAbiAno, Narendra Chirmule, Rocio D. Marchese	2006	42
12	Innate Immune Responses to Adenoviral Vector-Mediated Acute Pancreatitis Pancreas ·Alexander L. Shifrin, Narendra Chirmule, Guangping Gao, James M. Wilson, Steven E. Raper	2005	21
13	Long‐term transgene expression in cardiac and skeletal muscle following fetal administration of adenoviral or adeno‐associated viral vectors in mice The Journal of Gene Medicine ·Sarah Bouchard, Tippi C. MacKenzie, Antoneta Radu, Satoshi Hayashi, William H. Peranteau, Narendra Chirmule, Alan W. Flake	2003	33
14	Memory T cells and vaccines Vaccine ·Mark T. Esser, Rocio D. Marchese, Lisa Kierstead, Lynda Tussey, Fubao Wang, Narendra Chirmule, Michael W. Washabaugh	2003	147
15	Acute Cytokine Response to Systemic Adenoviral Vectors in Mice Is Mediated by Dendritic Cells and Macrophages Molecular Therapy ·Yi Zhang, Narendra Chirmule, Guangping Gao, NIKHAT JAHAN, Maria A. Croyle, Bindu Joshi, John Tazelaar, James M. Wilson	2001	313
16	Th2-Dependent B Cell Responses in the Absence of CD40-CD40 Ligand Interactions The Journal of Immunology ·Narendra Chirmule, John Tazelaar, James M. Wilson	2000	18
17	A Phase I Study of Adenovirus-Mediated Transfer of the Human Cystic Fibrosis Transmembrane Conductance Regulator Gene to a Lung Segment of Individuals with Cystic Fibrosis Human Gene Therapy ·Jonathan B. Zuckerman, Cynthia B. Robinson, Anjelica M. Castillo, Richard Shell, Thomas J. Sferra, Narendra Chirmule, Susan Magosin, Kathleen J. Propert, Michal Hnaníček, Joseph V. Hughes, John Tazelaar, Colleen Baker, Mitchell J. Goldman, James M. Wilson	1999	111
18	HIV gp120 inhibits T cell activation by interfering with expression of costimulatory molecules CD40 ligand and CD80 (B71) The Journal of Immunology ·Narendra Chirmule, Thomas W. McCloskey, Rong Hu, Vaniambadi S. Kalyanaraman, Savita Pahwa	1995	61
19	Improved Specificity of In Vitro Anti-HIV Antibody Production: Implications for Diagnosis and Timing of Transmission in Infants Born to HIV-Seropositive Mothers AIDS Research and Human Retroviruses ·Xueping Wang, Lindsey M. Medenblik, Talha Görücü, Elaine J. Abrams, Mahrukh Bamji, J.-M. Ranger, Narendra Chirmule, Naoki Oyaizu, Saroj Bakshi, Savita Pahwa	1994	16
20	Localization of B-Cell Stimulatory Activity of HIV-1 to the Carboxyl Terminus of gp41 AIDS Research and Human Retroviruses ·Narendra Chirmule, Vaniambadi S. Kalyanaraman, Carl Saxinger, Flossie Wong‐Staal, John Ghrayeb, Savita Pahwa	1990	32

About Narendra Chirmule

Narendra Chirmule is a scholar working on Virology, Immunology, Genetics, Infectious Diseases and Radiology, Nuclear Medicine and Imaging, having authored 115 papers that have together received 7.8k indexed citations. Recurring topics across this work include Virus-based gene therapy research (28 papers), HIV Research and Treatment (27 papers), Biosimilars and Bioanalytical Methods (27 papers), Immune Cell Function and Interaction (23 papers), Monoclonal and Polyclonal Antibodies Research (21 papers), CAR-T cell therapy research (17 papers), T-cell and B-cell Immunology (13 papers) and Protein purification and stability (12 papers). The work is most often cited by research in Virology (1.1k citations), Genetics (3.8k citations), Immunology (2.0k citations), Infectious Diseases (1.1k citations) and Molecular Biology (4.1k citations). Narendra Chirmule has collaborated with scholars based in United States, India and Japan. Frequent co-authors include James M. Wilson, Guangping Gao, Savita Pahwa, Steven E. Raper, Mark L. Batshaw, Nelson A. Wivel, Yi Zhang, Adam Bagg, Naoki Oyaizu and Frank S. Lee. Their work appears in journals such as Human Gene Therapy, Journal of Virology, The AAPS Journal, Clinical and Vaccine Immunology and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact